心力衰竭治疗选择的细胞基础。 - Suppr

Cellular basis for therapeutic choices in heart failure.

作者信息

Opie Lionel H

出版信息

Circulation. 2004 Oct 26;110(17):2559-61. doi: 10.1161/01.CIR.0000146803.14063.F7.

DOI:10.1161/01.CIR.0000146803.14063.F7

PMID:15505109

Abstract

摘要

相似文献

Cellular basis for therapeutic choices in heart failure.

Circulation. 2004 Oct 26;110(17):2559-61. doi: 10.1161/01.CIR.0000146803.14063.F7.

Conclusions on the management of heart failure.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5 Suppl 1:S34-6. doi: 10.3317/jraas.2004.023.

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

Circulation. 2004 Nov 16;110(20):3281-8. doi: 10.1161/01.CIR.0000147274.83071.68.

Reassessing guidelines for heart failure.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5 Suppl 1:S28-33. doi: 10.3317/jraas.2004.022.

[Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].

Ter Arkh. 2008;80(9):5-12.

Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.

Pharmacotherapy. 2009 Jan;29(1):31-48. doi: 10.1592/phco.29.1.31.

[Antiarrhythmic drug therapy in patients with heart failure].

Nihon Rinsho. 2007 May 28;65 Suppl 5:369-74.

[Anti-atherosclerotic effect].

Nihon Rinsho. 2006 Jul;64 Suppl 5:518-23.

Pharmacologic therapies across the continuum of left ventricular dysfunction.

Am J Cardiol. 2008 Sep 8;102(5A):21G-28G. doi: 10.1016/j.amjcard.2008.06.007.

Strategies to attenuate pathological remodeling in heart failure.

Curr Opin Cardiol. 2009 May;24(3):223-9. doi: 10.1097/HCO.0b013e32832a11ff.

引用本文的文献

Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies.

Toxicol Appl Pharmacol. 2022 Dec 1;456:116267. doi: 10.1016/j.taap.2022.116267. Epub 2022 Oct 12.

Effects of exercise training on heart rate variability in children and adolescents with pulmonary arterial hypertension: a pilot study.

Cardiovasc Diagn Ther. 2021 Aug;11(4):1028-1036. doi: 10.21037/cdt-20-263.

Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension.

Front Pediatr. 2015 Jul 7;3:63. doi: 10.3389/fped.2015.00063. eCollection 2015.

Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.

Tex Heart Inst J. 2010;37(5):538-46.

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21. doi: 10.2215/CJN.03670807. Epub 2008 Jan 9.

Thyroid (dys)function in heart failure: is it a potential target for medical treatment?

Vasc Health Risk Manag. 2005;1(2):97-100. doi: 10.2147/vhrm.1.2.97.64076.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cellular basis for therapeutic choices in heart failure.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献